Mupirocin Focus Pharmaceuticals Ltd

Mupirocin, the active ingredient in Mupirocin Focus Pharmaceuticals Ltd, is a Antibiotic presented as a unknown/unknown for cutaneous use. It treats impetigo, secondary bacterial skin infections and folliculitis in patients requiring topical antibacterial therapy.

GNH USA supplies Mupirocin Focus Pharmaceuticals Ltd as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibacterial agent used to manage skin infections caused by susceptible bacteria.

Impetigo: Reduces bacterial load and promotes healing of superficial skin lesions. Secondary bacterial skin infections: Controls infection in compromised skin areas. Folliculitis: Eliminates bacterial colonisation of hair follicles and alleviates inflammation.

Mupirocin may cause local skin reactions when applied.

Common Side Effects: - Application site irritation: mild redness or discomfort. - Itching: localized pruritus at the site of use. - Burning sensation: transient warmth during application. - Dry skin: mild desiccation around the treated area. - Pain: brief tenderness at the application site. - Rash: non‑specific erythematous eruption.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe itching, swelling, and blistering. - Hypersensitivity reaction: systemic urticaria or angioedema. - Stevens‑Johnson syndrome: rare, severe mucocutaneous reaction. - Neutropenia: very rare systemic absorption leading to low white‑blood‑cell count. - Severe skin necrosis: extensive tissue damage at the application site.

Before using mupirocin, consider the following safety measures.

Pregnancy: Consult a healthcare professional; safety data are limited. Breastfeeding: Avoid application on nipples if the infant may ingest the product. Age: Use with caution in children under two months unless directed by a clinician. Allergy: Discontinue immediately if signs of hypersensitivity appear. Concurrent antibiotic therapy: Monitor for potential resistance development. Store at ambient temperature: Keep in the original container, protect from moisture and light.

Mupirocin may interact with other medications, primarily affecting topical efficacy.

Major Interactions (Avoid): - Systemic antibiotics (e.g., clindamycin): may reduce the topical agent's effectiveness. - Other topical antibacterial agents: concurrent use can increase risk of local irritation.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may enhance systemic absorption of mupirocin. - Occlusive dressings: can increase drug concentration and irritation. - Antifungal creams: may alter skin flora and affect treatment outcome.